Cetuximab monotherapy is active in patients with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN). Results of phase II study
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 22 5502-, 2004